Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)

Steven J Yakubov,Nicolas M Van Mieghem,Michael J Reardon,Patrick W Serruys,Hemal Gada,Mubashir Mumtaz,G Michael Deeb,Susheel Kodali,Isaac George,Stephan Windecker,Neal Kleiman,Stanley J Chetcuti,Carlos Sanchez,Harold L Dauerman,Shuzhen Li,Jeffrey J Popma

The American Journal of Cardiology（2020）

引用 4|浏览81

暂无评分

摘要

•One hundred and ninety-seven matched pairs of patients receiving TAVR with Evolut R or SAVR were analyzed.•TAVI resulted in significantly better hemodynamics outcomes compared to SAVR.•At 30 days, all-cause mortality or disabling stroke significantly lower with TAVI.•At 1 year, clinical outcomes were comparable between TAVI and SAVR.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要